Assenagon Asset Management S.A. Makes New Investment in HealthEquity, Inc. (NASDAQ:HQY)

Assenagon Asset Management S.A. acquired a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 15,128 shares of the company’s stock, valued at approximately $1,452,000.

Other hedge funds also recently made changes to their positions in the company. Paladin Wealth LLC bought a new position in shares of HealthEquity during the third quarter worth approximately $39,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in HealthEquity during the second quarter worth approximately $73,000. GAMMA Investing LLC increased its stake in HealthEquity by 57.8% during the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock worth $77,000 after acquiring an additional 344 shares during the period. Quarry LP raised its holdings in HealthEquity by 418.8% in the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after acquiring an additional 1,089 shares in the last quarter. Finally, 1620 Investment Advisors Inc. acquired a new position in HealthEquity in the 3rd quarter valued at $112,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at HealthEquity

In related news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction on Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the completion of the sale, the director now owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. This trade represents a 11.04 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now directly owns 19,061 shares of the company’s stock, valued at $1,843,579.92. The trade was a 56.74 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 34,289 shares of company stock worth $3,355,718 in the last quarter. 2.20% of the stock is currently owned by company insiders.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $104.71 on Friday. The stock has a market cap of $9.07 billion, a price-to-earnings ratio of 96.06, a PEG ratio of 1.84 and a beta of 0.54. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $106.35. The firm’s 50-day simple moving average is $99.44 and its 200 day simple moving average is $87.18.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the prior year, the firm earned $0.40 EPS. As a group, research analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have issued reports on HQY. Royal Bank of Canada increased their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. BTIG Research upped their price target on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Mizuho started coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective on the stock. The Goldman Sachs Group began coverage on shares of HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective for the company. Finally, Barrington Research raised their target price on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Monday, December 2nd. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $110.71.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.